Non-specific code 2015 ICD-9-CM Diagnosis Code 203.1
Plasma cell leukemia
  • 2015
  • Non-Billable Code

  • There are 3 ICD-9-CM codes below 203.1 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim.
Clinical Information
  • A rare, aggressive variant of multiple myeloma characterized by the circulation of excessive plasma cells in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease
  • An aggressive plasma cell neoplasm with usually short survival. It is characterized by the presence of neoplastic plasma cells in the peripheral blood. The peripheral blood plasma cells comprise more than 20% of the peripheral blood white cells. It may be the initial presentation of a plasma cell neoplasm or manifest as a terminal complication of plasma cell myeloma. Lymphadenopathy and organomegaly are frequent clinical signs, whereas bone pain and osteolytic lesions are less frequently present
  • Rare type of acute leukemia in which the predominating cell in the peripheral blood is the plasma cell; it is often seen in conjunction with multiple myeloma and may be a variant form of that disease
Applies To
  • Plasmacytic leukemia
ICD-9-CM Volume 2 Index entries containing back-references to 203.1:
  • Leukemia, leukemic (congenital) (M9800/3) 208.9
    • plasma cell (M9830/3) 203.1
    • plasmacytic (M9830/3) 203.1
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 203.1 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.